Comprehensive Management of Musculoskeletal Disorders in Hemophilia (1973)

Chapter: Cryoprecipitate Utilization in the Home Transfusion Program

Previous Chapter: Therapy of Hemophilia A and B with Plasma and Plasma Fractions
Suggested Citation: "Cryoprecipitate Utilization in the Home Transfusion Program." National Research Council. 1973. Comprehensive Management of Musculoskeletal Disorders in Hemophilia. Washington, DC: The National Academies Press. doi: 10.17226/20386.
Page 67
Suggested Citation: "Cryoprecipitate Utilization in the Home Transfusion Program." National Research Council. 1973. Comprehensive Management of Musculoskeletal Disorders in Hemophilia. Washington, DC: The National Academies Press. doi: 10.17226/20386.
Page 68
Suggested Citation: "Cryoprecipitate Utilization in the Home Transfusion Program." National Research Council. 1973. Comprehensive Management of Musculoskeletal Disorders in Hemophilia. Washington, DC: The National Academies Press. doi: 10.17226/20386.
Page 69
Suggested Citation: "Cryoprecipitate Utilization in the Home Transfusion Program." National Research Council. 1973. Comprehensive Management of Musculoskeletal Disorders in Hemophilia. Washington, DC: The National Academies Press. doi: 10.17226/20386.
Page 70
Suggested Citation: "Cryoprecipitate Utilization in the Home Transfusion Program." National Research Council. 1973. Comprehensive Management of Musculoskeletal Disorders in Hemophilia. Washington, DC: The National Academies Press. doi: 10.17226/20386.
Page 71
Next Chapter: Early Management of Joint and Soft Tissue Bleeding
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.